# Regorafenib

## Stivarga 40mg \(28\#/Bot\)

| 藥物代碼 | OSTV |
| :--- | :--- |
| 適應症 | Colorectal cancer: Treatment of patients with metastatic colorectal cancer \(mCRC\) who have previously received the following therapies, including fluoropyrimidine-, oxaliplatin-, irinotecan-based chemotherapy, and anti-vascular endothelial growth factor \(anti-VEGF\) therapy; If KRAS is a wild type, the patient needs to have received anti-epidermal growth factor receptor \(anti-EGFR\) therapy. Gastrointestinal stromal tumors: Treatment of locally advanced, unresectable or metastatic gastrointestinal stromal tumors in patients who have previously received imatinib mesylate and sunitinib malate. Hepatocellular carcinoma: Treatment of hepatocellular carcinoma \(HCC\) patients who have received sorafenib treatment. |
| 副作用 | Hypertension, Fatigue, dysphonia, pain, fever, headache, Palmar-plantar erythrodysesthesia, rash, alopecia, Hypocalcemia, hypophosphatemia, hyponatremia, hypokalemia, hypothyroidism, Appetite decreased, lipase increased, diarrhea, mucositis, weight loss, amylase increased, nausea, vomiting, Anemia, lymphopenia, thrombocytopenia, INR increased, hemorrhage, neutropenia, AST increased, ALT increased, hyperbilirubinemia, Stiffness, Proteinuria, Infection. |
| 禁忌 | Hypersensitivity to regorafenib, any component of the formulation, or sorafenib. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Dosing: Adult Oral: 160 mg once daily for the first 21 days of each 28-day cycle; continue until disease progression or unacceptable toxicity. Dosing: Geriatric Refer to adult dosing. |
| 肝功能異常 | 需 調 整 劑 量  Preexisting severe impairment \(total bilirubin &gt;3 times ULN\): Use is not recommended |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 儘量避免 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Potential Toxicity\(Mother\) 無\(很少\)資料 - 避免使用\(母體\) |
| 附帶說明 | \(UPp to date\) Pregnancy Risk Factor: D \(參考書\):尚未確立 Lactation:Excretion in breast milk unknown/not recommended 仿單: 懷孕分級D; 授乳:禁用 |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

